Shenzhen Weiguang Biological Products Co., Ltd.
SZSE:002880.SZ
33.35 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 253.957 | 217.545 | 121.121 | 204.992 | 189.585 | 171.152 | 156.637 | 154.749 | 153.227 | 124.855 | 100.542 | 88.881 | 71.445 |
| Depreciation & Amortization
| 118.27 | 87.309 | 65.258 | 55.484 | 45.723 | 39.789 | 41.826 | 41.594 | 40.079 | 40.069 | 39.184 | 29.717 | 15.718 |
| Deferred Income Tax
| 0 | 0 | 0.415 | 1.102 | 0.405 | 0.29 | -1.054 | -1.133 | 0.109 | -0.279 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -229.615 | 66.231 | -169.958 | -19.123 | 67.716 | -29.544 | -104.73 | -182.828 | -85.079 | -39.995 | -30.744 | -108.056 | 14.304 |
| Accounts Receivables
| -144.477 | 88.21 | 33.523 | -2.722 | -15.571 | -61.715 | -82.374 | -81.606 | -5.338 | -1.524 | 4.927 | -3.939 | 41.281 |
| Inventory
| -119.903 | -50.56 | -183.834 | -37.755 | 83.802 | 28.27 | -53.749 | -86.197 | -85.027 | -31.085 | -27.56 | -76.517 | -41.16 |
| Accounts Payables
| 0 | 35.623 | -20.062 | 20.252 | -0.921 | 3.611 | 32.447 | -13.892 | 5.177 | -7.108 | 0 | 0 | 0 |
| Other Working Capital
| 34.765 | -7.041 | 0.415 | 1.102 | 0.405 | 0.29 | -50.981 | -96.631 | -0.052 | -8.91 | -3.184 | -31.539 | 55.465 |
| Other Non Cash Items
| 35.153 | 26.854 | -15.222 | 5.533 | 0.934 | 4.304 | 5.807 | 15.099 | 18.179 | 25.161 | 25.185 | 10.388 | 14.413 |
| Operating Cash Flow
| 177.765 | 397.939 | 1.199 | 246.887 | 303.958 | 185.701 | 99.54 | 28.614 | 126.406 | 150.09 | 134.166 | 20.929 | 115.88 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -255.5 | -328.854 | -327.373 | -240.827 | -189.193 | -77.794 | -84.512 | -61.361 | -59.911 | -85.864 | -38.375 | -56.928 | -172.948 |
| Acquisitions Net
| 0 | -22.386 | 0.117 | 0.23 | 20.605 | 3.303 | 0.003 | 0.087 | 0.008 | 0.09 | 0 | 0 | 0 |
| Purchases Of Investments
| -5 | -1 | -0.117 | -49.48 | -14 | -4.95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 2.13 | 0 | 1.106 | -0.23 | -20.605 | -3.303 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 20.168 | 0.073 | -160.992 | 0.23 | 0.605 | -17.898 | 4.652 | 0.797 | 4.608 | 3.934 | 7.187 | 7.728 | 41.604 |
| Investing Cash Flow
| -238.202 | -352.167 | -487.259 | -290.077 | -202.588 | -100.642 | -79.859 | -60.564 | -55.303 | -81.93 | -31.188 | -49.2 | -131.344 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 160.994 | -21.159 | 503.478 | -57 | 82 | -29 | -41 | -224.825 | -68.55 | 8.3 | -22.5 | 84.375 | 155 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -65.877 | -65.601 | -45.36 | -40.5 | -35.683 | -32.538 | -57.335 | -94.017 | -58.802 | -69.429 | -37.321 | -125.669 | -110.412 |
| Other Financing Activities
| -11.395 | -1.42 | 2.11 | 2.647 | -0.792 | 21.201 | -0 | 614.837 | 16.93 | -19.338 | 0 | 0 | -0 |
| Financing Cash Flow
| 83.722 | -88.18 | 447.903 | -96.175 | 65.525 | -40.337 | -98.335 | 309.012 | -110.422 | -80.467 | -59.821 | -41.294 | 44.588 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 23.286 | -42.408 | -38.157 | -139.365 | 166.895 | 44.723 | -78.654 | 277.063 | -39.32 | -12.307 | 43.157 | -69.565 | 29.124 |
| Cash At End Of Period
| 274.73 | 251.445 | 293.853 | 332.01 | 471.375 | 304.48 | 259.757 | 338.411 | 61.348 | 100.668 | 112.974 | 69.818 | 139.383 |